Skip to main content

Table 5 Multivariate analysis of risk factors for 28-day mortality

From: The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea

Factors

OR

95% CI

p value

ESBL producing

11.53

2.11–63.05

0.005

Previous antibiotics use

5.09

0.94–27.54

0.059

SOFA score

1.32

1.03–1.69

0.029

  1. ESBL extended spectrum β-lactamases, SOFA score the Sequential Organ Failure Assessment score, OR odd ratio, CI confidence interval
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us